statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024 Curis to Report Second Quarter 2024 Financial and Operating Results and Host...

Curis to Present at Upcoming Healthcare Conference in July

Curis to Present at Upcoming Healthcare Conference in July Curis to Present at Upcoming Healthcare Conference in July PR Newswire LEXINGTON, Mass., July 10, 2024 LEXINGTON, Mass., July 10, 2024...

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire LEXINGTON, Mass., July 8, 2024 LEXINGTON, Mass...

Curis Announces Additional Data from TakeAim Leukemia Study

Curis Announces Additional Data from TakeAim Leukemia Study Curis Announces Additional Data from TakeAim Leukemia Study PR Newswire LEXINGTON, Mass., May 14, 2024 Data update expands AML dataset from...

Curis to Present Updated Data from the TakeAim Leukemia Study

Curis to Present Updated Data from the TakeAim Leukemia Study Curis to Present Updated Data from the TakeAim Leukemia Study PR Newswire LEXINGTON, Mass., May 10, 2024 LEXINGTON, Mass., May 10, 2024...

Curis Provides First Quarter 2024 Business Update

Curis Provides First Quarter 2024 Business Update Curis Provides First Quarter 2024 Business Update PR Newswire LEXINGTON, Mass., May 7, 2024 Management to host conference call today at 8:30 a.m. ET...

Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024

Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024 Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024 PR Newswire...

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire LEXINGTON, Mass., April 5, 2024 LEXINGTON, Mass...

Curis to Present at Upcoming Healthcare Conferences in April

Curis to Present at Upcoming Healthcare Conferences in April Curis to Present at Upcoming Healthcare Conferences in April PR Newswire LEXINGTON, Mass., April 4, 2024 LEXINGTON, Mass., April 4, 2024...

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Curis, Inc. (NASDAQ: CRIS)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Curis, Inc. (NASDAQ: CRIS) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Curis...

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Volume	11,499.00
52-Wk High	$17.49
52-Wk Low	$3.80

CRIS Curis Inc

About

Feed

News

Sentiment

Earnings

Fundamentals